Bicycle Therapeutics Plc - ADR

+0.80 (+3.57%)
6:17:01 PM EDT: $24.28 +1.08 (+4.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)693.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.88 Million
Adjusted EPS-$1.08
See more estimates
10-Day MA$21.52
50-Day MA$24.37
200-Day MA$24.62
See more pivots

Bicycle Therapeutics Plc - ADR Stock, NASDAQ:BCYC

Granta Park Great Abington, Portway Building, Cambridge, Cambridgeshire CB21 6GS
Phone: +44.1223.261503
Number of Employees: 236


Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.